Johnstone CN, Osellame LD, Cao Z, McDonald AF, et al. DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of (177)Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma. J Nucl Med 2025;66:385-390.
PMID: 39884775